BDR 09 LTD

Company number 13042467 ·

Active - Proposal to Strike off

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ESTE MEDICAL 6 LTD - Analysis Report

Company Number: 13042467

Analysis Date: 2025-07-19 12:15 UTC

Financial Health Assessment Report for ESTE MEDICAL 6 LTD


1. Financial Health Score: D

Explanation:
The company’s financial condition reflects significant distress, primarily due to persistent negative net current assets and net liabilities over multiple years. The balance sheet shows minimal current assets (£16) against current liabilities of £436, resulting in a net current liability of -£420 as of the latest financial year. This consistent shortfall signals an unhealthy liquidity position that threatens operational viability without external intervention or restructuring.


2. Key Vital Signs

Metric 2023 Value Interpretation
Current Assets £16 Extremely low liquidity reserve; insufficient to cover short-term obligations.
Current Liabilities £436 Relatively high immediate financial obligations compared to assets.
Net Current Assets -£420 Negative working capital indicates cash flow stress; company cannot meet short-term debts from current assets.
Net Assets (Equity) -£420 Negative equity means liabilities exceed assets; company is technically insolvent on a balance sheet basis.
Shareholder Funds -£420 Indicates accumulated losses or capital erosion, reflecting weak financial foundation.
Employee Count 1 Micro entity with minimal staff, suggesting limited operational scale.
Account Category Micro Filing requirements are minimal, but financial distress is evident despite smaller scale.

3. Diagnosis: Symptoms of Financial Distress

  • Liquidity Crisis: The company shows persistent negative net current assets, a clear symptom of cash flow problems akin to a patient struggling to circulate blood efficiently. This means the company is unable to pay off its immediate debts with available liquid assets, risking default or creditor actions.

  • Capital Erosion: Negative shareholders’ funds denote that the company has been operating at a loss or has taken on liabilities exceeding its assets. This resembles a body losing vital nutrients needed for growth and repair, limiting the company’s ability to invest or sustain operations.

  • Stagnant Financial Position: Over the last four years, the financial position has barely improved, showing a chronic condition rather than an acute event. The company's financial health is not improving, indicating systemic issues or ineffective management of resources.

  • Limited Scale and Operations: Being a micro-entity with one employee and minimal assets suggests the business may be dependent on a narrow revenue stream or founder investment, increasing vulnerability to market or operational shocks.


4. Recommendations: Prescriptions for Financial Wellness

  1. Immediate Cash Flow Management:

    • Prioritize collection of any outstanding receivables and reduce discretionary expenditures to improve liquidity.
    • Consider short-term financing options such as overdrafts or bridging loans to cover immediate liabilities.
  2. Restructuring Liabilities:

    • Engage with creditors to negotiate extended payment terms or debt restructuring to relieve immediate pressure.
    • Explore potential capital injections from shareholders or external investors to restore positive equity.
  3. Operational Review:

    • Conduct a thorough business model review to identify unprofitable activities draining resources.
    • Assess opportunities to increase revenues, possibly through diversification or enhanced marketing.
  4. Strategic Planning:

    • Develop a turnaround plan with clear financial targets and milestones, monitored regularly to track progress.
    • Consider professional financial advisory support to diagnose deeper issues and develop restructuring strategies.
  5. Compliance and Governance:

    • Maintain timely filings and statutory compliance to avoid penalties or regulatory issues that could exacerbate financial strain.

Medical Analogy Summary

The company's financial health resembles a patient with chronic heart failure: the vital signs (liquidity and equity) show persistent weakness, indicating the "organs" (business operations) are struggling to sustain life. Without urgent intervention to stabilize cash flow and restructure liabilities, the prognosis remains guarded, with risk of insolvency looming.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 19 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.